A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible newly diagnosed multiple myeloma.

DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment ... death through various immune-mediated mechanisms and immunomodulatory effects.

This CAR helps the T cells recognize and destroy cells expressing BCMA, which is primarily found in malignant multiple myeloma B-lineage cells, late-stage B cells, and plasma cells. The CARVYKTI ...